Cargando…
Breaking down the evidence for bevacizumab in advanced cervical cancer: past, present and future
Despite the introduction of screening and, latterly, vaccination programs in the developed world, globally cervical cancer remains a significant health problem. For those diagnosed with advanced or recurrent disease even within resource rich communities, prognosis remains poor with an overall surviv...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881045/ https://www.ncbi.nlm.nih.gov/pubmed/27231568 http://dx.doi.org/10.1186/s40661-015-0015-0 |